#01-Efficacy and Safety of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis in a Phase 3 Trial
SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters November 16-20, 2022, Miami, FL 1. Efficacy and Safety of Roflumilast Foam 0.3% in Patients with